Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Zintellect
- Center for Drug Evaluation and Research (CDER)
- National University of Singapore
- University of South-Eastern Norway
- Hong Kong Polytechnic University
- NTNU - Norwegian University of Science and Technology
- Nanyang Technological University
- Queen's University Belfast;
- RMIT University
- The University of Queensland
- University of Birmingham
- University of Sydney
- 2 more »
- « less
-
Field
-
analyses of single-cell and spatial omics to advance precision medicine. Dr Chen’s research team develops AI algorithms for spatial and single-cell omics, integrates publicly available datasets into a
-
– “A human-like progressive learning paradigm for embodied AI: Meta skills for robots by watching and imagination”. They will be required to: (a) identify irreducible low-level sensorimotor units
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 11 hours ago
in the Office of Translational Sciences at the FDA is recognized for excellence in the application and communication of statistical science in drug regulation and development. We play a central role in
-
melanoma clinical guidelines project, undertaking evidence synthesis activities that contribute to the compilation and development of clinical practice guidelines for melanoma management. The successful
-
epidemiology, remote sensing, machine learning and/or meta-analyses to identify impacts of environmental change on infectious disease dynamics and design targeted surveillance approaches; - Develop and implement
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 11 hours ago
just medicines. Research Project: Under the guidance of a mentor, you will implement two-stage meta-analytic models and weighted least squares correlation methods to estimate the surrogacy strength
-
supervisors and wider project collaborators. The role will include developing review protocols, screening studies, extracting data, undertaking risk-of-bias assessment, synthesising evidence, performing meta
-
causes of death among individuals initiating ESKD therapy. Participate in systematic reviews and meta-analyses examining factors associated with CKD awareness and related public health outcomes. Develop
-
claims and electronic health data to examine healthcare utilization, quality of care, treatment patterns, and outcomes among individuals with diabetes. Participate in systematic reviews and meta-analyses
-
of the pros and cons of IPD meta-analysis projects, and the importance of sample size calculations in medical research Fluency in relevant models, techniques or methods and ability to contribute to developing